| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 121 | (2-fluoro-5,6,11,12-tetraselenotetracene)2-bromide electroconductive like metal, manufacture and use | JP20925883 | 1983-11-09 | JPS59181284A | 1984-10-15 | BURUNO HIRUTEI; KAARU BUE MAIYAA; GURETEI RIISU |
| 122 | Telluropyrylium compound | JP11265282 | 1982-07-01 | JPS5832876A | 1983-02-25 | MAIKERU REI DETEI; BURUUSU JIYON MURAI; JIEROMU HAWAADO BAARUSUTAIN |
| 123 | JPS5532709B2 - | JP10068177 | 1977-08-24 | JPS5532709B2 | 1980-08-26 | |
| 124 | Compositions | JP10068177 | 1977-08-24 | JPS5371075A | 1978-06-24 | DENISU KURINTON GURIIN |
| 125 | SYNTHETIC METHOD OF FUSED HETEROAROMATIC COMPOUND AND FUSED HETEROAROMATIC COMPOUND, AND INTERMEDIATE THEREOF | US16033574 | 2018-07-12 | US20180323381A1 | 2018-11-08 | Eigo MIYAZAKI; Jeong II PARK; Hyun Bum KANG; Eun Kyung LEE |
| A method of synthesizing a fused heteroaromatic compound includes obtaining a first intermediate from a first compound represented by Chemical Formula 1 and a second compound represented by Chemical Formula 2, obtaining a second intermediate including a ring having a chalcogen element from the first intermediate, and obtaining a fused heteroaromatic compound by a cyclization reaction of the second intermediate. | ||||||
| 126 | SYNTHETIC METHOD OF FUSED HETEROAROMATIC COMPOUND AND FUSED HETEROAROMATIC COMPOUND AND INTERMEDIATE THEREFOR AND SYNTHETIC METHOD OF INTERMEDIATE | US15645257 | 2017-07-10 | US20180130952A1 | 2018-05-10 | Eun Kyung LEE; Eigo MIYAZAKI; Jeong II PARK; Hyun Bum KANG |
| A method of making a chemical product includes reacting a compound represented by Chemical Formula 1 with a metal alkyl chalcogenide using a palladium catalyst and a tertiary phosphine catalyst to obtain a first intermediate represented by Chemical Formula 2, obtaining a second intermediate represented by Chemical Formula 3 from the first intermediate, obtaining a third intermediate from the second intermediate and a compound represented by Chemical Formula 4, obtaining a fourth intermediate including a chalcogen-containing ring from the third intermediate, and performing a cyclization reaction of the fourth intermediate to obtain a fused heteroaromatic compound. A fused heteroaromatic compound obtained by the method, an intermediate thereof, and a synthetic method of the intermediate are disclosed. | ||||||
| 127 | Native ligation process | US14386490 | 2013-03-18 | US09796758B2 | 2017-10-24 | Oleg Melnyk; Laurent Raibaut; Nathalie Ollivier |
| A method for producing a polypeptide, includes at least one native ligation step using a peptide functionalized with a selenium group. The selenium peptides and compounds are also described. | ||||||
| 128 | ORGANOTELLURIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | US15505197 | 2015-08-20 | US20170269094A1 | 2017-09-21 | MARK NITZ; LANDON J. EDGAR; BRADLEY G. WOUTERS; DAVID HEDLEY; LISA M. WILLIS; MATTHEW A. LUMBA; HANUEL PARK; RAVI N. VELLANKI |
| A compound of formula (I) as described herein and methods and uses thereof as probes in the mass tagging of biosensors or biologically active materials for use in mass cytometry analysis of tissue samples such as in the detection, labelling and quantification of oxygen-deprived cells by using, for example, tellurophene-tagged 2-nitroimidazole. | ||||||
| 129 | INTERMEDIATE FOR HETEROACENE COMPOUND AND SYNTHETIC METHOD OF HETEROACENE COMPOUND USING ITS INTERMEDIATE | US15293873 | 2016-10-14 | US20170117484A1 | 2017-04-27 | EIGO MIYAZAKI; Jeong Il PARK; Eun Kyung LEE |
| An intermediate of a heteroacene compound is represented by Chemical Formula 1. | ||||||
| 130 | 3-SUBSTITUTED TELLUROPHENES AND RELATED COMPOUNDS | US14440305 | 2013-11-04 | US20150295178A1 | 2015-10-15 | Dwight Seferos; Ashlee Jahnke |
| Monomeric 3-substituted tellurophene compounds, as well as their use in the synthesis of oligomeric and/or polymeric compounds consisting of two or more tellurophene-2,5-diyl groups which are covalently linked to each other are disclosed, as is the use of said oligomers and polymers in devices such as diodes and solar cells, electrodes and semiconductors. | ||||||
| 131 | SELENO-COMPOUNDS AND THERAPEUTIC USES THEREOF | US14512193 | 2014-10-10 | US20150191446A1 | 2015-07-09 | Carl Herbert SCHIESSER; Corin STORKEY; Michael Jonathan DAVIES |
| Compounds and compositions, useful as antioxidants and in particular to selenium containing compounds of formula (I): wherein n is 1, 2, or 3; m is 2, 3, 4, or 5; and each R] is independently-(optionally substituted C1-C3 alkylene)p-OH, where p is 0 or 1, or a salt thereof. These seleno-compounds may be used in the treatment of diseases or conditions associated with increased levels of oxidants produced by myeloperoxidase (MPA), such as for instance, atherosclerosis and diabetes. | ||||||
| 132 | ORGANOSELENIUM MATERIALS AND THEIR USES IN ORGANIC LIGHT EMITTING DEVICES | US14611468 | 2015-02-02 | US20150155499A1 | 2015-06-04 | Raymond Kwong; Bin Ma; Chuanjun Xia; Chun Lin |
| The present invention provides organoselenium compounds comprising dibenzoselenophene, benzo[b]selenophene or benzo[c]selenophene and their uses in organic light emitting devices. | ||||||
| 133 | NATIVE LIGATION PROCESS | US14386490 | 2013-03-18 | US20150045506A1 | 2015-02-12 | Oleg Melnyk; Laurent Raibaut; Nathalie Ollivier |
| A method for producing a polypeptide, includes at least one native ligation step using a peptide functionalized with a selenium group. The selenium peptides and compounds are also described. | ||||||
| 134 | NOVEL CHALCOGEN-CONTAINING ORGANIC COMPOUND AND USE THEREOF | US14378684 | 2013-02-20 | US20150014673A1 | 2015-01-15 | Junichi Takeya; Toshihiro Okamoto; Tauto Nakanishi |
| [Problem] To provide an organic compound that is easy to synthesize, and has excellent chemical stability, semiconductor characteristics (high carrier mobility) and high solubility in a solvent.[Solution] A compound represented by formula (1) or formula (2): wherein, in formula (1), X is oxygen, sulfur or selenium; n is 0 or 1; R1 to R3 are hydrogen, fluorine, alkyl having 1 to 20 carbons, aryl, pyridyl, furyl, thienyl, thiazolyl or the like. However, except for a case where X is selenium, a case where all of R1 to R3 are simultaneously hydrogen is excluded, and a case where X is sulfur and all of R1 are simultaneously butyl is also excluded. In formula (2), X is oxygen, sulfur or selenium; n is 0 or 1; R1 to R2 are hydrogen, alkyl having 1 to 20 carbons, aryl, pyridyl, furyl, thienyl, thiazolyl or the like; however, a case where all of R1 to R2 are simultaneously hydrogen is excluded. | ||||||
| 135 | Multifunctional Materials And Composites | US14379021 | 2013-02-15 | US20140371443A1 | 2014-12-18 | Dong-Kyun Seo; Ki-Wan Jeon |
| Forming multifunctional materials and composites thereof includes contacting a first material having a plurality of oxygen-containing functional groups with a chalcogenide compound, and initiating a chemical reaction between the first material and the chalcogenide compound, thereby replacing oxygen in some of the oxygen-containing functional groups with chalcogen from the chalcogen-containing compound to yield a second material having chalcogen-containing functional groups and oxygen-containing functional groups. The first material is a carbonaceous material or a macromolecular material. A product including the second material is collected and may be processed further to yield a modified product or a composite. | ||||||
| 136 | SELENOPHENE-FUSED AROMATIC COMPOUND AND MANUFACTURING METHOD THEREOF | US14228493 | 2014-03-28 | US20140213790A1 | 2014-07-31 | Dongyeol Lim; Do-Hyun Nam; Rashmi Dubey; Hangeun Lee |
| The present disclosure relates to a method for more easily and economically producing a selenophene-fused aromatic compound derivative containing various substituents and the selenophene-fused aromatic compound produced according to the method, and the selenophene-fused aromatic compound can be used for various purposes such as an intermediate of an anti-bacterial or anticancer substance, an indicator of which color is changed depending on a solvent, or a fluorescent substance. | ||||||
| 137 | SELENO-COMPOUNDS AND THERAPEUTIC USES THEREOF | US13881594 | 2011-10-28 | US20140206658A1 | 2014-07-24 | Carl Herbert Schiesser; Corin Storkey; Michael Jonathan Davies |
| The present invention relates to compounds and compositions useful as antioxidants and in particular to selenium containing compounds of formula (I): wherein n is 1, 2, or 3; m is 2, 3, 4, or 5; and each R] is independently —(optionally substituted C1-C3 alkylene) p-OH, where p is 0 or 1, or a salt thereof. The invention also relates to the use of these seleno-compounds in the treatment of diseases or conditions associated with increased levels of oxidants produced by myeloperoxidase (MPO), such as for instance, atherosclerosis. | ||||||
| 138 | Imaging agents | US12946027 | 2010-11-15 | US08435493B2 | 2013-05-07 | Mark M. Goodman |
| The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled with halogen isotopes such as fluorine-18, iodine-123, iodine-124, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77, bromine-82, astatine-210, astatine-211, and other astatine isotopes. These compounds can also be labeled with technetium and rhenium isotopes using known chelation complexes. The compounds disclosed herein bind tumor tissues in vivo with high specificity and selectivity when administered to a subject. Preferred compounds show a target to non-target ratio of at least 2:1, are stable in vivo and substantially localized to target within 1 hour after administration. Preferred compounds include 1-amino-2-[18F]fluorocyclobutyl-1-carboxylic acid (2-[18F]FACBC) and 1-amino-2-[18F]fluoromethylcyclobutyl-1-carboxylic acid (2-[18F]FMACBC). The labeled amino acid compounds of the invention are useful as imaging agents in detecting and/or monitoring tumors in a subject by PET or SPECT. | ||||||
| 139 | Oxime ester compound and photopolymerization initiator containing the same | US12740452 | 2007-12-25 | US08202679B2 | 2012-06-19 | Daisuke Sawamoto; Nobuhide Tominaga |
| An oxime ester compound of formula (I) useful as a photopolymerization initiator. A photopolymerization initiator having the oxime ester compound as an active ingredient is activated through efficient absorption of light of long wavelength, e.g., 405 nm or 365 nm, to exhibit high sensitivity. In formula (I), R1 and R2 are each R11, OR11, COR11, SR11, CONR12R13, or CN; R11, R12, and R13 are each hydrogen, a C1-C20 alkyl group, C6-C30 aryl group, a C7-C30 arylalkyl group, or a C2-C20 heterocyclic group; R3 and R4 are each R11, OR11, SR11, COR11, CONR12R13, NR12COR11, OCOR11, COOR11, SCOR11, OCSR11, COSR11, CSOR11, CN, halogen, or a hydroxyl group; a and b is each 0 to 4; X is oxygen, sulfur, selenium, CR31R32, CO, NR33, or PR34; and R31, R32, R33, and R34 each have the same meaning as R1. | ||||||
| 140 | ORGANOSELENIUM COMPOUNDS AND USES THEREOF | US12959285 | 2010-12-02 | US20110301235A1 | 2011-12-08 | Daniel A. Erlanson; Stig K. Hansen |
| Provided herein are organoselenium compounds and pharmaceutical compositions thereof. Also provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders using the compounds and pharmaceutical compositions provided herein. | ||||||
QQ群二维码
意见反馈
意见反馈